BeyondSpring BYSI Q1 2026 Earnings Narrowing Loss and No Revenue as ClinicalStage Biotech Advances Pipeline ONEW Q1 2026 Earnings Deep EPS Miss Overshadows Modest Share Gain DRD Q3 2014 Earnings NarrowerThanExpected Loss as Gold Producer Cuts Costs LCID Q1 2026 Earnings EPS Miss Widens Amid Revenue Visibility Challenges HOWL Q1 2026 Earnings EPS Beats Estimates as Biotech Continues Pipeline Progress AirSculpt Technologies Q1 2026 Earnings EPS Beats Estimates Despite Loss Stock Rises